We are proud to announce the launch of FluA/FluB/SarsCov2 kit: an Italian solution to oppose the global COVID-19 outbreak! Performance evaluation was conducted in collaboration with the University of Milan - Department of Biomedical Sciences for Health - Reference Laboratory for Respiratory Infections Surveillance. FluA/FluB/SarsCov2 allows the multiplex detection and identification of influenza A, Influenza B and Sars Cov 2 RNA according to the CDC indications. Product development was carried out by Clonit R&D Team, whose hard work made available a kit with great clinical value in such a short time.
The standardization of the manufacturing process, the strict control of raw materials and finished products and the cross-checks in outer reference labs have made Clonit able to assure the highest standards of care and quality.
The company is ISO 9001:2008 and ISO 13485:2003 Certificated.